학술논문
Ruxolitinib Reverses Checkpoint Inhibition By Downregulating PD-L1 and PD-L2 Expression on Both Tumor and Stromal Cells in Multiple Myeloma
Document Type
Abstract
Author
Source
In Blood 13 November 2019 134 Supplement 1:4402-4402
Subject
Language
ISSN
0006-4971